This topic contains a solution. Click here to go to the answer

Author Question: You are treating a patient suffering from severe anaphylaxis. Which of the following dosages of ... (Read 67 times)

Evvie72

  • Hero Member
  • *****
  • Posts: 519
You are treating a patient suffering from severe anaphylaxis. Which of the following dosages of epinephrine would you be likely to administer?
 
  a. Epinephrine 1:1000, 0.30.5 mg IM
  b. Epinephrine 1:1000, 0.30.5 mg IV
  c. Epinephrine 1:10,000, 0.30.5 mg IV
  d. Epinephrine 1:10,000, 0.050.1 mg IV

Question 2

_____ reactions are the chief reactions of catabolism.
 
  Fill in the blank(s) with correct word



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

6ana001

  • Sr. Member
  • ****
  • Posts: 311
Answer to Question 1

d
Rationale: In cases of severe anaphylaxis, the dosage of epinephrine 1:10,000 should be 0.050.1 mg intravenously. This is 510 of the normal dosage used in cardiac arrest. It may need to be administered every 35 minutes due to the half-life.

Answer to Question 2

Hydrolysis




Evvie72

  • Member
  • Posts: 519
Reply 2 on: Jul 3, 2018
Wow, this really help


at

  • Member
  • Posts: 359
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

In inpatient settings, adverse drug events account for an estimated one in three of all hospital adverse events. They affect approximately 2 million hospital stays every year, and prolong hospital stays by between one and five days.

Did you know?

Individuals are never “cured” of addictions. Instead, they learn how to manage their disease to lead healthy, balanced lives.

Did you know?

Drying your hands with a paper towel will reduce the bacterial count on your hands by 45–60%.

Did you know?

About 80% of major fungal systemic infections are due to Candida albicans. Another form, Candida peritonitis, occurs most often in postoperative patients. A rare disease, Candida meningitis, may follow leukemia, kidney transplant, other immunosuppressed factors, or when suffering from Candida septicemia.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library